XPrize FloodLAMP Submission - Part 7 Targets.xlsx

	A	B	C
1	Primer Sequences OR Antigen target/antibody
2	Target Number	Target Gene	Sequence/antibody
3	Numeric	Text	Text
4	1	ORF1 As1e_FIP	TCAGCACACAAAGCCAAAAATTTATTTTTCTGTGCAAAGGAAATTAAGGAG
5	2	ORF1 As1e_BIP	TATTGGTGGAGCTAAACTTAAAGCCTTTTCTGTACAATCCCTTTGAGTG
6	3	ORF1 As1_F3	CGGTGGACAAATTGTCAC
7	4	ORF1 As1_B3	CTTCTCTGGATTTAACACACTT
8	5	ORF1 As1_LF	TTACAAGCTTAAAGAATGTCTGAACACT
9	6	ORF1 As1_LB	TTGAATTTAGGTGAAACATTTGTCACG
10	7	N N2-FIP	TTCCGAAGAACGCTGAAGCGGAACTGATTACAAACATTGGCC
11	8	N N2-BIP	CGCATTGGCATGGAAGTCACAATTTGATGGCACCTGTGTA
12	9	N N2-F3	ACCAGGAACTAATCAGACAAG
13	10	N N2-B3	GACTTGATCTTTGAAATTTGGATCT
14	11	N N2-LF	GGGGGCAAATTGTGCAATTTG
15	12	N N2-LB	CTTCGGGAACGTGGTTGACC
16	13	RNaseP-F3	TTGATGAGCTGGAGCCA
17	14	RNaseP-B3	CACCCTCAATGCAGAGTC
18	15	RNaseP-FIP	GTGTGACCCTGAAGACTCGGTTTTAGCCACTGACTCGGATC
19	16	RNaseP-BIP	CCTCCGTGATATGGCTCTTCGTTTTTTTCTTACATGGCTCTGGTC
20	17	RNaseP-LF	ATGTGGATGGCTGAGTTGTT
21	18	RNaseP-LB	CATGCTGAGTACTGGACCTC
22
23	We are currently using the As1e and N2 combined for maximum sensitivity.
24	We may move to running them in 2 separate reactions to have independent results for confidence in positives.
25	RNAseP is standard but we plan to move to an RNA only internal control.
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100